Viewing Study NCT00079261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:16 PM
Ignite Modification Date: 2025-12-26 @ 2:52 PM
Study NCT ID: NCT00079261
Status: COMPLETED
Last Update Posted: 2012-09-24
First Post: 2004-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Small Intestine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None contiguous stage II grade 3 follicular lymphoma View
None noncontiguous stage II grade 3 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None contiguous stage II adult diffuse large cell lymphoma View
None noncontiguous stage II adult diffuse large cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None anaplastic large cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None adult grade III lymphomatoid granulomatosis View
None small intestine lymphoma View